Available drugs and supplements for rapid deployment for treatment of COVID-19

D Cicka, VP Sukhatme - Journal of molecular cell biology, 2021 - academic.oup.com
Materials and methods Coronaviruses are classified into four genera: α, β, γ, and δ. All
seven coronaviruses known to cause respiratory infections in humans fall into the α or β …

[HTML][HTML] 抗致病性冠状病毒活性化合物及其潜在靶标蛋白研究进展

王晓宇, 彭诚, 杨延青, 石禹龙, 朱正诞, 穆凯洁… - 药学学报, 2020 - html.rhhz.net
已知人类致病性冠状病毒可分为7 种, 即HCoV-229E, HCoV-OC43, HCoV-HKU1, HCoV-
NL63, SARS-CoV, MERS-CoV 和SARS-CoV-2. 其中, 后3 种冠状病毒分别引起的严重急性 …

[PDF][PDF] Mostafa F. Al‑Hakkani1, 2Ε, Gamal A. Gouda1, Sedky HA Hassan3, 4, Mahmoud MA Mohamed2 & Adham M. Nagiub1

A Azithromycin, C Cefixime - Scientific Reports, 2022 - academia.edu
Pharmaceutical wastewater contamination via azithromycin antibiotic and the continuous
emergence of some strains of bacteria, cancer, and the Covid‑19 virus. Azithromycin …

Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration into human lung cells

H Caohuy, O Eidelman, T Chen, Q Yang, A Bera… - BioRxiv, 2021 - biorxiv.org
To initiate SARS-CoV-2 infection, the Receptor Binding Domain (RBD) on the viral spike
protein must first bind to the host receptor ACE2 protein on pulmonary and other ACE2 …

Broad-spectrum mono-and combinational drug therapies for global viral pandemic preparedness

A Ianevski, R Yao, RM Simonsen, V Myhre, E Ravlo… - bioRxiv, 2022 - biorxiv.org
Broadly effective antiviral therapies must be developed to be ready for clinical trials, which
should begin soon after the emergence of new life-threatening viruses. Here, we pave the …

[PDF][PDF] Treatment of two cases of COVID-19 with ciclesonide resulted in amelioration of pneumonia symptoms

T Tsuchida, Y Yamasaki, H Kunishima, K Sato… - Jpn. J …, 2020 - antibiotics.or.jp
We have observed two cases in which ciclesonide, an inhaled steroid drug for bronchial
asthma, had a possibly useful effect on novel coronavirus disease (coronavirus disease …

Systematic review and meta-analysis identifies potential host therapeutic targets in COVID-19

N Parkinson, N Rodgers, MH Fourman, B Wang… - medRxiv, 2020 - medrxiv.org
An increasing body of literature describes the role of host factors in COVID-19 pathogenesis.
There is a need to combine diverse, multi-omic data in order to evaluate and substantiate …

[HTML][HTML] Unleashing high content screening in hit detection–Benchmarking AI workflows including novelty detection

E Kupczyk, K Schorpp, K Hadian, S Lin, D Tziotis… - Computational and …, 2022 - Elsevier
Complex mixtures containing natural products are still an interesting source of novel drug
candidates. High content screening (HCS) is a popular tool to screen for such. In particular …

In Vivo and In Vitro Models for the Study of Sars-CoV-2 Transmission and the Development of Antiviral Therapies

BAR Rodríguez - 2023 - search.proquest.com
Small animal models have been a challenge for the study of SARS-CoV-2 transmission, with
most investigators using golden hamsters or ferrets. Mice have the advantages of low cost …

Computational strategies for the discovery of small molecule therapeutics against SARS-CoV-2 virus

H Mslati - 2022 - open.library.ubc.ca
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused a global
healthcare crisis due to COVID-19 pandemic. In absence of efficacious antiviral drugs …